Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-26
1994-11-29
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, A61K 3144
Patent
active
053691121
ABSTRACT:
Pyrrolo quinoline esters, oxazopyrrolo quinolines and esters of oxazopyrrolo quinolines are effective at treating cataracts through their active oxygen scavenging activity.
REFERENCES:
patent: 4898870 (1990-02-01), Narutomi
"Collection of Summaries of Lectures (5) at 109th Meeting of Japan Pharmacological Society", p. 42, 1989.
"Current Therapeutic Research", 44:891-901 1988.
"PQQ and Quinoprotein", Jongejan, Duine, ed. pp. 162-164 (1989), Kluwer Academic Publishers.
"Life Science" 45: 593-398 (1989).
"Hiroshima J. Med. Sci" 38(1): 49-51 (1987).
Chem Abst. vol. 110, No. 4, Jan. 23, 1989 Abst. #29104N.
Chem Abst vol. 110, No. 10, Mar. 6, 1989, Abst #82492P.
Hamagishi et al, The Journal of Pharmacology and Experimental Therapeutics 255(3): 980-985, 1990.
Akaike Takaaki
Maeda Hiroshi
Nishigoori Hideo
Urakami Teizi
Yoshida Chieko
Burke Henry T.
Cintins Marianne M.
Jarvis William R. A.
Mitsubishi Gas Chemical Company Inc.
LandOfFree
Method of treating cataracts caused by active oxygen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cataracts caused by active oxygen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cataracts caused by active oxygen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-74317